| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.42 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.43 | 0.009 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |